Materials and Methods

Tissue preparation and treatment
Nonpregnant and near-term pregnant (~140 days gestation) sheep were anesthetized with thiamylal (10 mg/kg) administered via the external left jugular vein. The ewes were then intubated and anesthesia was maintained on 1.5% to 2.0% halothane in oxygen throughout surgery. An incision in the abdomen was made and the uterus exposed. The uterine arteries were isolated and removed without stretching and placed into a modified Krebs solution as described previously. 1 Briefly, the middle uterine artery from each uterine horn was dissected and 4 th generation branches from the middle uterine artery were isolated in the Krebs solution. These vessels have been extensively examined in our previous studies, and we have demonstrated that the characteristics of PKC-mediated effects are not altered among branches of small uterine arteries. [2] [3] [4] [5] [6] [7] [8] The Krebs solution was oxygenated with a mixture of oxygen-carbon dioxide (95:5%). After removal of the tissues, animals were killed with T-61 (euthanasia solution, Hoechst-Rousel, Somervile, NJ). Arterial preparations were incubated in a complete medium of phenol red-free Dulbecco's Modified Eagle's Medium (DMEM, Mediatech Cellgro Inc., VA) with 1% charcoal-stripped fetal bovine serum for 48 h at 37 °C in a humidified incubator with 5% CO 2 /95% air, as described previously, 1 in the absence or presence of E 2 β (Sigma, St. Louis, MO), progesterone (Sigma), ICI 182,780 (Tocris Bioscience, Ellisville, MO), and RU 486 (Sigma), respectively. All procedures and protocols used in the present study were approved by the Animal Research Committee of Loma Linda University and followed the guidelines by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Measurement of myogenic tone
Resistance-sized uterine artery segments (~150 µm in diameter) were dissected. After the hormonal or antagonist treatments for 48 h, arteries were cannulated in an organ chamber (Living Systems, Burlington, VT), followed by placement on the stage of an inverted microscope. The proximal cannula was connected to a pressure transducer and reservoir of physiological salt solution (PSS), and the intraluminal pressure was controlled by a servo-system to set transmural pressures. The distal cannula was connected to a luer-lock valve that was open to flush the lumen during the initial cannulation. Following cannulation, the valve was closed, and all measurements were conducted under no-flow conditions. Arterial diameter was recorded using the SoftEdge Acquisition Subsystem (IonOptix Milton, MA), as described previously. 4 After being mounted, the vessels were equilibrated in PSS for 10 min at an intraluminal pressure of 20 mmHg, followed by increasing the pressure from 20 to 70 mmHg, and returning to 20 mmHg immediately. The vessels were then allowed to equilibrate at 20 mmHg in the presence of a nitric oxide synthase inhibitor N G -nitro-L-arginine (L-NNA, 100 µM) for 30 min. After the equilibration period, the pressure was increased in a stepwise manner from 10 to 100 mmHg in 10-mmHg increments, and each pressure was maintained for 3 min to allow vessel diameter to stabilize before measurement. The passive pressure-diameter relationship was conducted in Ca 
Contraction studies
The fourth branches of middle uterine arteries were separated from the surrounding tissue, and cut into 2-mm ring segments. In some rings the endothelium was removed, as described previously. 1 After the hormonal and/or antagonist treatments for 48 h, isometric tensions were measured in tissue baths at 37 °C, as described previously. 1 After 60 min of equilibration, each ring was stretched to the optimal resting tension as determined by the tension developed in response to 120 mM KCl added at each stretch level. Concentration-response curves of phorbol 12,13-dibutyrate (PDBu, Sigma) were obtained by a cumulative addition of the agonist in approximate one-half log increments. Some arteries were treated with the steroid hormones in the presence of an ERK1/2 inhibitor PD098059 (30 μM, Sigma) for 48 h. To determine the acute effect of steroid hormones, some arteries were treated in the tissue bath with the steroids for 30 min, and then stimulated with increasing concentrations of PDBu. EC 50 values for the agonist in each experiment were taken as the molar concentration at which the contraction-response curve intersected 50% of the maximum response, and were expressed as pD 2 (-logEC 50 ) values.
Measurement of ERK1/2 mRNA levels
Extracellular signal-regulated kinase (ERK1/2) mRNA was quantified by coupled RT-PCR amplification in a single tube assay as described previously. 9 Total cellular RNA was isolated from the uterine arteries using TRizol reagent (Gibco BRL, Life Technologies, Rockville, MD, USA). RNA (0.1 μg) was used for first-strand cDNA synthesis with AMV reverse transcriptase (RT) and oligo (dT) as primer. Polymerase chain reaction (PCR) amplifications were carried out on a portion of the cDNA produced using specific oligonucleotide primers for ERK1 and 2. The primer sequences are as follows: ERK1 forward: 5'tgctggaccggatgttaac3', reverse: 5'gaatgcagcccacagaccagatgtc3'; ERK2 forward: 5'gcagccaacatggcggcgg3', reverse: 5'tctggatctgcaacacgggc3'. PCR products were resolved on a 1% agarose gel containing ethidium bromide. The band intensities at the size of 661 (ERK1) and 539 (ERK2) bases were measured and analyzed by using densitometry, as described previously.
3
Western immunoblotting analysis ERK1/2 protein abundance was measured in freshly isolated uterine arteries and after the hormonal and/or antagonist treatments. Tissues were homogenized in a lysis buffer containing 150 mM NaCl, 50 mM Tris HCl, 10 mM EDTA, 0.1% Tween 20, 0.1% β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride, 5 μg/ml leupeptin, and 5 μg/ml aprotinin, PH 7.4. Homogenates were then centrifuged at 4 °C for 10 min at 10,000g and the supernatants were collected. Proteins were quantified in the supernatant with a protein assay kit (Bio-Rad). Samples with equal proteins were loaded onto 7.5% polyacrylamide gel with 0.1% sodium dodecyl sulfate (SDS), and were separated by electrophoresis at 100 V for 2 h. Proteins were then transferred onto nitrocellulose membranes. Nonspecific binding sites in the membranes were blocked by an overnight incubation at 4 °C in Tris-buffered saline solution (TBS) containing 5% dry milk. The membranes were incubated with primary antibodies against ERK1/2 and phospho-ERK1/2 (Tyr 202 /Tyr 204 ) antibodies (New England Biolabs, Beverly, MA). After washing, membranes were incubated with secondary horseradish peroxidase-conjugated antibodies. Proteins were visualized with enhanced chemiluminescence reagents, and blots were exposed to Hyperfilm. Results were quantified with the Kodak electrophoresis documentation and analysis system and Kodak ID image analysis software.
Measurement of PKC isozyme translocation
After the hormonal or antagonist treatments for 48 h, tissues were snap-frozen in liquid N 2 and homogenized in ice-cold homogenization buffer containing Tris-HCl 20 mM, sucrose 250 mM, EDTA 5 mM, EGTA 5 mM, PMSF 1 mM, β-mercaptoethanol 10 mM, and benzamide 1 mM. The cytosolic and particulate fractions were separated as previously described. 10 Briefly, the homogenate was centrifuged at 100,000g for 60 min at 4 °C, and the supernatant was used as the cytosolic fraction. The pellet corresponding to the membrane particulate fraction was solubilized in buffer containing Triton X-100 at a final concentration of 0.1% by stirring on ice for 45 min at 4 °C, followed by centrifugation at 100,000g for 60 min at 4 °C to remove insoluble membrane particles. The supernatant was collected and was referred to as the membrane particulate fraction. Protein concentrations were determined with a protein assay kit (Bio-Rad). Proteins from cytosolic and particulate fractions were subjected to electrophoresis on 10% SDS-PAGE as described above. The membranes were incubated with primary antibodies against PKCα, βI, βII, δ, ε, and ζ (Santa Cruz Biotechnology, Santa Cruz, CA). Bands were detected and analyzed as described above.
Data analysis
Concentration-response curves were analyzed by computer-assisted nonlinear regression to fit the data using GraphPad Prism (GraphPad software, San Diego, CA). Results were expressed as means ± SEM obtained from the number (n) of experimental animals given. Differences were evaluated for statistical significance (P < 0.05) by ANOVA or t-test, where appropriate. 
